Ledger.Open graph →
SEC Form D · filed January 25, 2016

LIGAND PHARMACEUTICALS INC

Offering
$85.4M
Sold
$85.4M
Exemption
Rule 506(c)
Industry
Pharmaceuticals
Location
LA JOLLA, CA
Type
—

Rule 506(c): private placement that may advertise publicly; all investors must be verified accredited.

People & firms on this filing (24)

John M. Lamattina · LA JOLLA, CADirectorJohn S. Kozarich · LA JOLLA, CADirectorStephen M. Sabba · LA JOLLA, CADirectorMatthew W. Foehr · LA JOLLA, CADirectorJohn L. Higgins · South San Francisco, CAExec · DirectorTodd S. Davis · LA JOLLA, CADirectorSunil M. Patel · LA JOLLA, CADirectorMatthew W. Korenberg · LA JOLLA, CADirectorDavid M. Knott · Calgary, Alberta, CanadaDirectorJason S. Aryeh · LA JOLLA, CADirectorCharles S. Berkman · LA JOLLA, CADirectorMelanie S. Herman · LA JOLLA, CADirectorStephen M. Sabba · LA JOLLA, CADirectorMatthew W. Foehr · LA JOLLA, CADirectorJohn L. Higgins · South San Francisco, CAExec · DirectorJohn M. Lamattina · LA JOLLA, CADirectorTodd S. Davis · LA JOLLA, CADirectorSunil M. Patel · LA JOLLA, CADirectorJohn S. Kozarich · LA JOLLA, CADirectorMatthew W. Korenberg · LA JOLLA, CADirectorDavid M. Knott · LA JOLLA, CADirectorJason S. Aryeh · LA JOLLA, CADirectorCharles S. Berkman · LA JOLLA, CADirectorMelanie S. Herman · LA JOLLA, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗